Results 191 to 200 of about 6,286,028 (355)
British Journal of Clinical Pharmacology, EarlyView.Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Correction: Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France. [PDF]
BioDrugsSingier A +4 more
europepmc +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
Access to Medicines in Bulgaria and North Macedonia: Legislative, Pricing, and Reimbursement Perspectives. [PDF]
Pharmacy (Basel)Todorova A +4 more
europepmc +1 more source
How Does Price Presentation Influence Consumer Choice? The Case of Life Insurance Products
, 2015 Carin Huber +2 more
semanticscholar +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
British Journal of Clinical Pharmacology, EarlyView.Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
Huimin Insurance and unequal economic welfare between urban and rural areas: evidence from Chinese cities. [PDF]
Front Public HealthMa J, Li S, Xue W.
europepmc +1 more source
Testing for Asymmetric Information Using 'Unused Observables' in Insurance Markets: Evidence from the U.K. Annuity Market [PDF]
This paper tests for asymmetric information in the U.K. annuity market of the 1990s by trying to identify 'unused observables,' attributes of individual insurance buyers that are correlated both with subsequent claims experience and with insurance demand
James Poterba, Amy Finkelstein
core
British Journal of Clinical Pharmacology, EarlyView.Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić +4 more
wiley +1 more source
Regional Yield Insurance for Arable Crops in EU-27
Replaced with revised version of paper 11/18/08.Area yield insurance, index insurance, yield risk, Agricultural Finance, Risk and Uncertainty,
Gallego, Francisco J. +3 more
core